 Kelly Sullivan
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 16 | 2024 | 478 | 2.660 |
Why?
| | Tumor Suppressor Protein p53 | 11 | 2023 | 511 | 2.190 |
Why?
| | Proteome | 4 | 2024 | 443 | 1.130 |
Why?
| | Apoptosis | 14 | 2023 | 2503 | 0.920 |
Why?
| | Liposarcoma | 1 | 2023 | 27 | 0.840 |
Why?
| | Transcriptome | 6 | 2024 | 887 | 0.810 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 5 | 2023 | 64 | 0.780 |
Why?
| | Interferons | 5 | 2023 | 194 | 0.780 |
Why?
| | Genes, p53 | 2 | 2012 | 70 | 0.770 |
Why?
| | Piperazines | 5 | 2022 | 342 | 0.760 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 24 | 0.710 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.710 |
Why?
| | Transcriptional Activation | 3 | 2022 | 366 | 0.710 |
Why?
| | Azetidines | 1 | 2020 | 40 | 0.700 |
Why?
| | Databases, Genetic | 1 | 2021 | 232 | 0.670 |
Why?
| | Neoplasms | 8 | 2023 | 2469 | 0.670 |
Why?
| | Tumor Suppressor Proteins | 4 | 2018 | 317 | 0.590 |
Why?
| | Metabolome | 1 | 2021 | 338 | 0.580 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 81 | 0.570 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2015 | 66 | 0.560 |
Why?
| | Hypersensitivity | 1 | 2020 | 249 | 0.560 |
Why?
| | Sulfonamides | 1 | 2020 | 496 | 0.540 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1356 | 0.510 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 891 | 0.500 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 2061 | 0.500 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2015 | 193 | 0.490 |
Why?
| | Isoquinolines | 1 | 2015 | 41 | 0.480 |
Why?
| | Mitochondrial Turnover | 1 | 2015 | 5 | 0.480 |
Why?
| | Immunity, Innate | 2 | 2020 | 804 | 0.460 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 586 | 0.400 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1443 | 0.400 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 43 | 0.380 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 596 | 0.380 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 74 | 0.370 |
Why?
| | Patient Selection | 1 | 2015 | 662 | 0.370 |
Why?
| | Fibroblasts | 1 | 2016 | 948 | 0.360 |
Why?
| | Imidazoles | 3 | 2020 | 234 | 0.350 |
Why?
| | Interferon-alpha | 3 | 2020 | 194 | 0.350 |
Why?
| | Cerebellar Neoplasms | 2 | 2022 | 156 | 0.320 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1706 | 0.320 |
Why?
| | Medulloblastoma | 2 | 2022 | 198 | 0.320 |
Why?
| | Membrane Proteins | 1 | 2015 | 1119 | 0.300 |
Why?
| | Trisomy | 2 | 2019 | 77 | 0.290 |
Why?
| | Signal Transduction | 7 | 2024 | 4924 | 0.280 |
Why?
| | Pyrimidines | 2 | 2024 | 459 | 0.270 |
Why?
| | HCT116 Cells | 3 | 2017 | 78 | 0.270 |
Why?
| | Inflammation | 1 | 2017 | 2735 | 0.260 |
Why?
| | Humans | 37 | 2024 | 129378 | 0.260 |
Why?
| | Biomarkers | 3 | 2022 | 3972 | 0.260 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 25 | 0.230 |
Why?
| | Datasets as Topic | 2 | 2022 | 109 | 0.230 |
Why?
| | Erythropoiesis | 1 | 2024 | 51 | 0.230 |
Why?
| | Autophagy | 2 | 2018 | 268 | 0.220 |
Why?
| | Heme | 1 | 2024 | 77 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 4 | 2023 | 637 | 0.220 |
Why?
| | Animals | 15 | 2024 | 35346 | 0.210 |
Why?
| | Receptors, Interferon | 2 | 2023 | 50 | 0.210 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 20 | 0.210 |
Why?
| | Cell Proliferation | 6 | 2023 | 2391 | 0.210 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 42 | 0.210 |
Why?
| | Glutamine | 1 | 2023 | 98 | 0.210 |
Why?
| | Piperidines | 1 | 2024 | 196 | 0.210 |
Why?
| | Mice | 10 | 2024 | 16935 | 0.210 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.200 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 147 | 0.200 |
Why?
| | Centrosome | 2 | 2023 | 64 | 0.200 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 431 | 0.200 |
Why?
| | Purines | 2 | 2020 | 172 | 0.190 |
Why?
| | Nuclear Proteins | 3 | 2017 | 663 | 0.190 |
Why?
| | Cell Line, Tumor | 6 | 2023 | 3215 | 0.190 |
Why?
| | Blood | 1 | 2022 | 103 | 0.190 |
Why?
| | Hedgehog Proteins | 2 | 2023 | 188 | 0.180 |
Why?
| | Autoimmunity | 3 | 2024 | 862 | 0.180 |
Why?
| | Cell Death | 1 | 2022 | 354 | 0.180 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.180 |
Why?
| | Cilia | 2 | 2023 | 179 | 0.180 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.180 |
Why?
| | Pyrazoles | 2 | 2022 | 405 | 0.180 |
Why?
| | Data Mining | 1 | 2021 | 110 | 0.170 |
Why?
| | Cytokines | 4 | 2024 | 2015 | 0.170 |
Why?
| | Cell Line | 5 | 2021 | 2780 | 0.170 |
Why?
| | RNA Helicases | 1 | 2020 | 23 | 0.170 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 179 | 0.160 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1418 | 0.160 |
Why?
| | DNA Repair | 1 | 2021 | 207 | 0.160 |
Why?
| | Case-Control Studies | 3 | 2022 | 3375 | 0.160 |
Why?
| | Protein Domains | 2 | 2017 | 253 | 0.160 |
Why?
| | Metabolomics | 2 | 2021 | 652 | 0.150 |
Why?
| | Kynurenine | 1 | 2019 | 114 | 0.150 |
Why?
| | Complement System Proteins | 2 | 2021 | 313 | 0.150 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 15 | 0.150 |
Why?
| | Proteomics | 2 | 2023 | 1062 | 0.150 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 55 | 0.140 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 406 | 0.140 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2017 | 44 | 0.140 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 412 | 0.140 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 182 | 0.140 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.140 |
Why?
| | Hypoxia | 1 | 2024 | 1081 | 0.140 |
Why?
| | Female | 12 | 2024 | 68686 | 0.140 |
Why?
| | Young Adult | 4 | 2024 | 12415 | 0.140 |
Why?
| | Caspases | 2 | 2015 | 245 | 0.130 |
Why?
| | Cell Cycle Checkpoints | 2 | 2020 | 95 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 387 | 0.130 |
Why?
| | Antigens | 1 | 2018 | 355 | 0.130 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 177 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 758 | 0.130 |
Why?
| | Proteolysis | 1 | 2017 | 165 | 0.130 |
Why?
| | Down-Regulation | 2 | 2017 | 636 | 0.130 |
Why?
| | Male | 9 | 2024 | 63595 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 161 | 0.120 |
Why?
| | Genomics | 1 | 2021 | 715 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 243 | 0.120 |
Why?
| | Adult | 7 | 2024 | 35512 | 0.120 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 5438 | 0.120 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 11 | 0.120 |
Why?
| | Pyrones | 1 | 2015 | 9 | 0.120 |
Why?
| | Caspase 8 | 1 | 2015 | 48 | 0.120 |
Why?
| | bcl-2-Associated X Protein | 1 | 2015 | 55 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2018 | 4082 | 0.120 |
Why?
| | Azepines | 1 | 2015 | 89 | 0.110 |
Why?
| | Transcription Factors | 2 | 2022 | 1650 | 0.110 |
Why?
| | Child, Preschool | 4 | 2024 | 10516 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2017 | 406 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2018 | 743 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 372 | 0.110 |
Why?
| | Morpholines | 1 | 2015 | 122 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2015 | 136 | 0.110 |
Why?
| | Aminobenzoates | 1 | 2013 | 7 | 0.110 |
Why?
| | Fluorouracil | 1 | 2015 | 199 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 232 | 0.110 |
Why?
| | Monocytes | 1 | 2016 | 551 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 623 | 0.100 |
Why?
| | Naphthalenes | 1 | 2013 | 57 | 0.100 |
Why?
| | RNA Interference | 1 | 2015 | 448 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2015 | 811 | 0.100 |
Why?
| | Ligands | 1 | 2015 | 622 | 0.100 |
Why?
| | Genes, Synthetic | 1 | 2012 | 14 | 0.100 |
Why?
| | Genes, Lethal | 1 | 2012 | 29 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 587 | 0.100 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 838 | 0.100 |
Why?
| | Liver | 1 | 2020 | 1839 | 0.100 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2015 | 197 | 0.100 |
Why?
| | Chronic Disease | 1 | 2017 | 1713 | 0.090 |
Why?
| | Child | 5 | 2024 | 20868 | 0.090 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 291 | 0.090 |
Why?
| | Telomerase | 1 | 2013 | 233 | 0.090 |
Why?
| | Lipids | 1 | 2015 | 625 | 0.090 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2058 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2831 | 0.080 |
Why?
| | Adolescent | 4 | 2024 | 20378 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2548 | 0.080 |
Why?
| | Cell Cycle | 1 | 2012 | 592 | 0.080 |
Why?
| | Infant | 2 | 2024 | 9023 | 0.080 |
Why?
| | Mitochondria | 1 | 2015 | 877 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1928 | 0.070 |
Why?
| | Mutation | 2 | 2015 | 3717 | 0.070 |
Why?
| | Middle Aged | 3 | 2024 | 31102 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2142 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2344 | 0.060 |
Why?
| | Pyrroles | 1 | 2024 | 202 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 56 | 0.050 |
Why?
| | Erythropoietin | 1 | 2024 | 86 | 0.050 |
Why?
| | Phenotype | 2 | 2023 | 3076 | 0.050 |
Why?
| | Proline | 1 | 2023 | 76 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 27 | 0.050 |
Why?
| | Centrioles | 1 | 2023 | 41 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 80 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 45 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2121 | 0.050 |
Why?
| | Stress, Physiological | 1 | 2024 | 413 | 0.050 |
Why?
| | Binding Sites | 2 | 2014 | 1252 | 0.050 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 30 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 156 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 244 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 307 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 21 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 33 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2023 | 4061 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 132 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 8 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 183 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 138 | 0.040 |
Why?
| | Gene Silencing | 1 | 2020 | 190 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 35 | 0.040 |
Why?
| | Phosphorylation | 1 | 2022 | 1713 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 89 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2019 | 181 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 376 | 0.040 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 26 | 0.040 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 13 | 0.040 |
Why?
| | Hexokinase | 1 | 2017 | 18 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 465 | 0.040 |
Why?
| | Cell Lineage | 1 | 2019 | 333 | 0.040 |
Why?
| | Deoxyglucose | 1 | 2017 | 52 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2017 | 116 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 611 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 13 | 0.030 |
Why?
| | Gene Editing | 1 | 2017 | 68 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1466 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 424 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 27 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 361 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 375 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2017 | 235 | 0.030 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2017 | 130 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2142 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 770 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 71 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 939 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1546 | 0.030 |
Why?
| | Glycolysis | 1 | 2017 | 311 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1156 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1106 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 14 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 125 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 55 | 0.030 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 39 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1471 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 945 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1719 | 0.030 |
Why?
| | Serine Proteases | 1 | 2013 | 20 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 857 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 857 | 0.030 |
Why?
| | Protein Transport | 1 | 2014 | 428 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 479 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2017 | 958 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 359 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2020 | 2707 | 0.020 |
Why?
| | Telomere-Binding Proteins | 1 | 2013 | 102 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 814 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 1901 | 0.020 |
Why?
| | HeLa Cells | 1 | 2013 | 608 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2070 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1181 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1086 | 0.020 |
Why?
| | RNA | 1 | 2014 | 883 | 0.020 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|